Obermeyer Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$943K Sell
15,553
-32
-0.2% -$1.86K 0.04% 117
2025
Q4
$841K Buy
15,585
+5,503
+55% +$265K 0.04% 130
2025
Q3
$455K Sell
10,082
-2,449
-20% -$114K 0.02% 181
2025
Q2
$580K Sell
12,531
-559
-4% -$27.4K 0.03% 145
2025
Q1
$798K Buy
13,090
+2,904
+29% +$169K 0.04% 114
2024
Q4
$576K Sell
10,186
-1
-0% -$56 0.03% 137
2024
Q3
$527K Sell
10,187
-250
-2% -$11.7K 0.03% 150
2024
Q2
$433K Sell
10,437
-600
-5% -$26.8K 0.02% 158
2024
Q1
$599K Sell
11,037
-148
-1% -$7.54K 0.04% 129
2023
Q4
$574K Buy
11,185
+450
+4% +$23.6K 0.04% 106
2023
Q3
$623K Buy
10,735
+384
+4% +$23.5K 0.05% 98
2023
Q2
$662K Sell
10,351
-215
-2% -$14.4K 0.05% 98
2023
Q1
$732K Sell
10,566
-7,635
-42% -$539K 0.05% 85
2022
Q4
$1.31M Hold
18,201
0.1% 63
2022
Q3
$1.29M Buy
18,201
+5,592
+44% +$406K 0.1% 61
2022
Q2
$971K Hold
12,609
0.07% 71
2022
Q1
$921K Buy
12,609
+1,000
+9% +$67.1K 0.06% 79
2021
Q4
$724K Sell
11,609
-2,043
-15% -$120K 0.04% 98
2021
Q3
$808K Sell
13,652
-2,108
-13% -$139K 0.04% 83
2021
Q2
$1.05M Sell
15,760
-1,183
-7% -$77.1K 0.06% 76
2021
Q1
$1.07M Sell
16,943
-8,775
-34% -$546K 0.07% 73
2020
Q4
$1.59M Sell
25,718
-1,700
-6% -$105K 0.11% 52
2020
Q3
$1.65M Sell
27,418
-5,615
-17% -$338K 0.12% 48
2020
Q2
$1.94M Sell
33,033
-362
-1% -$21.7K 0.16% 43
2020
Q1
$1.86M Sell
33,395
-4,805
-13% -$294K 0.2% 40
2019
Q4
$2.45M Buy
38,200
+26,687
+232% +$1.53M 0.22% 43
2019
Q3
$584K Sell
11,513
-4,087
-26% -$192K 0.05% 70
2019
Q2
$707K Sell
15,600
-350
-2% -$16.3K 0.06% 64
2019
Q1
$761K Sell
15,950
-997
-6% -$49.7K 0.07% 60
2018
Q4
$881K Sell
16,947
-750
-4% -$40.3K 0.09% 56
2018
Q3
$1.1M Sell
17,697
-703
-4% -$41.7K 0.09% 52
2018
Q2
$1.02M Sell
18,400
-1,079
-6% -$58.3K 0.09% 54
2018
Q1
$1.23M Sell
19,479
-891
-4% -$57.3K 0.11% 45
2017
Q4
$1.25M Buy
20,370
+551
+3% +$34.5K 0.11% 50
2017
Q3
$1.26M Buy
19,819
+4,805
+32% +$281K 0.11% 50
2017
Q2
$837K Buy
15,014
+300
+2% +$16.3K 0.07% 62
2017
Q1
$800K Sell
14,714
-931
-6% -$51.1K 0.07% 62
2016
Q4
$914K Sell
15,645
-3,079
-16% -$168K 0.09% 58
2016
Q3
$1.01M Sell
18,724
-636
-3% -$40.9K 0.1% 54
2016
Q2
$1.42M Sell
19,360
-1,310
-6% -$92.6K 0.14% 48
2016
Q1
$1.32M Sell
20,670
-275
-1% -$17.3K 0.12% 49
2015
Q4
$1.44M Hold
20,945
0.13% 45
2015
Q3
$1.24M Sell
20,945
-313
-1% -$19.9K 0.13% 45
2015
Q2
$1.42M Sell
21,258
-325
-2% -$21.4K 0.12% 52
2015
Q1
$1.39M Sell
21,583
-1,380
-6% -$86.4K 0.11% 64
2014
Q4
$1.36M Buy
22,963
+476
+2% +$26.8K 0.12% 67
2014
Q3
$1.15M Buy
22,487
+560
+3% +$28K 0.28% 31
2014
Q2
$1.06M Sell
21,927
-100
-0.5% -$4.93K 0.26% 32
2014
Q1
$1.14M Sell
22,027
-2,805
-11% -$149K 0.29% 31
2013
Q4
$1.32M Hold
24,832
0.34% 32
2013
Q3
$1.15M Sell
24,832
-490
-2% -$21.5K 0.32% 32
2013
Q2
$1.13M Buy
+25,322
New +$1.1M 0.31% 32

Other funds holding BMY

Obermeyer Wealth Partners's BMY Position: Q1 2026 in Review

Obermeyer Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.21% in Q1 2026, selling an estimated $1.86K and leaving 15,553 shares worth $943K. The position accounts for 0.04% of the portfolio, ranked #117.

Obermeyer Wealth Partners first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.45M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Obermeyer Wealth Partners held 15,553 shares of Bristol-Myers Squibb worth $943K as of Q1 2026.
  • Obermeyer Wealth Partners sold 32 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.86K.
  • Bristol-Myers Squibb made up 0.04% of Obermeyer Wealth Partners's portfolio in Q1 2026, its #117 holding.
  • Obermeyer Wealth Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Obermeyer Wealth Partners's Bristol-Myers Squibb position peaked at $2.45M in Q4 2019.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Obermeyer Wealth Partners's 13F filing for Q1 2026, filed 21 Apr 2026.